Log in to save to my catalogue

The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies

The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8406687

The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies

About this item

Full title

The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies

Publisher

New York: Nature Publishing Group US

Journal title

Nature immunology, 2020-08, Vol.21 (8), p.835-847

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Natural killer (NK) cells belong to the innate immune system and contribute to protecting the host through killing of infected, foreign, stressed or transformed cells. Additionally, via cellular cross-talk, NK cells orchestrate antitumor immune responses. Hence, significant efforts have been undertaken to exploit the therapeutic properties of NK ce...

Alternative Titles

Full title

The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8406687

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8406687

Other Identifiers

ISSN

1529-2908

E-ISSN

1529-2916

DOI

10.1038/s41590-020-0728-z

How to access this item